My worry is when the US trials finish and the time to get approvals for both arms (BTT and DT). As stated, around 1 year for BTT and 2 years for DT trial end dates. What will happen in between this is a concern. Europe/Asia sales wont be big enough to make up the shortfall IMO. Remember they need around 400 implants per year to make a profit.
- Forums
- ASX - By Stock
- VCR
- investor update
VCR
ventracor limited
investor update, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
P.HOTC
HotCopper
Frazer Bourchier, Director, President and CEO
Frazer Bourchier
Director, President and CEO
SPONSORED BY The Market Online